Young Hwan Kim is an Executive Officer at Mirae Asset Capital Life Science Inception I. See sector focus and contact routes.
Young Hwan Kim is an Executive Officer at Mirae Asset Capital Life Science Inception I, a venture capital firm based in New York. The firm is dedicated to investing in biotechnology and healthcare companies, with a strategic focus on advancing drug development. Their investment philosophy centers on a deep understanding of clinical data and evolving market dynamics within the life sciences sector. Mirae Asset Capital Life Science Inception I is committed to supporting companies that contribute to the delivery of safe and effective treatments for patients, ultimately aiming to improve global health outcomes. Young Hwan Kim's role involves leveraging this expertise to identify and nurture innovative ventures within the biotechnology and healthcare landscape.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in New York when building a target list.
Investors like Young Hwan Kim · Full investor directory · Investor access · Company funding database